This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1. AC Janssens , M Gwinn , LA Bradley (2008) A critical appraisal of the scientific basis of commercial genomic profiles used to assess health risks and personalize health interventions. Am J Hum Genet 82, 593–599.
5. S Hogarth , G Javitt & D Melzer (2008) The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues. Annu Rev Genomics Hum Genet 9, 161–182.
6. CR Lachance , LA Erby , BM Ford (2010) Informational content, literacy demands, and usability of websites offering health-related genetic tests directly to consumers. Genet Med 12, 304–312.
7. N Lewis , D Treise , SI Hsu (2011) DTC genetic testing companies fail transparency prescriptions. New Genet Soc 30, 291–307.
8. A Singleton , LH Erby , KV Foisie (2012) Informed choice in direct-to-consumer genetic testing (DTCGT) websites: a content analysis of benefits, risks, and limitations. J Genet Couns 21, 433–439.
9. R Sterling (2008) The on-line promotion and sale of nutrigenomic services. Genet Med Nov 10, 784–796.
10. Y Liu & Y Pearson (2008) Direct-to-consumer marketing of predictive medical genetic tests: assessment of current practices and policy recommendations. J Public Policy Market 27, 131–148.
11. A Harvey (2010) Genetic risks and healthy choices: creating citizen-consumers of genetic services through empowerment and facilitation. Sociol Health Illn 32, 365–381.
12. PM Saukko , M Reed , N Britten (2010) Negotiating the boundary between medicine and consumer culture: online marketing of nutrigenetic tests. Soc Sci Med 70, 744–753.
13. A Nordgren & ET Juengst (2009) Can genomics tell me who I am? Essentialist rhetoric in direct-to-consumer DNA testing. New Genet Soc 28, 157–172.
14. E Einsiedel & R Geransar (2009) Framing genetic risk: trust and credibility markers in online direct-to-consumer advertising for genetic testing. New Genet Soc 28, 339–362.
15. SE Gollust , BS Wilfond & SC Hull (2003) Direct-to-consumer sales of genetic services on the internet. Genet Med 5, 332–337.
16. R Geransar & E Einsiedel (2008) Evaluating online direct-to-consumer marketing of genetic tests: informed choices or buyers beware? Genet Test 12, 13–23.
17. CK Prahalad & V Ramaswamy (2004) Co-creation experiences: the next practice in value creation. J Interact Market 18, 5–14.
19. CS Bloss , NJ Schork & EJ Topol (2011) Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med 10, 364, 524–534.
20. KM James , CT Cowl , JC Tilburt (2011) Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic. Mayo Clin Proc 86, 933–940.
21. CM McBride , LM Koehly , SC Sanderson (2010) The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors? Annu Rev Public Health 31, 89–103.
22. I Arkadianos , AM Valdes , E Marinos . (2007) Improved weight management using genetic information to personalize a calorie controlled diet. Nutr J 6, 29.
23. DE Nielsen & A El-Sohemy (2012) A randomized trial of genetic information for personalized nutrition. Genes Nutr 7, 559–566.
24. R Hall , PM Saukko , PH Evans (2007) Assessing family history of heart disease in primary care consultations: a qualitative study. Fam Pract 24, 435–442.
25. FM Walter , J Emery , D Braithwaite (2004) Lay understanding of familial risk of common chronic diseases: a systematic review and synthesis of qualitative research. Ann Fam Med 2, 583–594.
26. PM Saukko , SH Richards , MH Shepherd (2006) Are genetic tests exceptional? Lessons from a qualitative study on thrombophilia. Soc Sci Med 63, 1947–1959.
27. A Bharadwaj (2002) Uncertain risk: genetic screening for susceptibility to haemochromatosis. Health Risk Soc 4, 227–240.
28. N Hallowell , C Foster , R Eeles (2004) Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer. Soc Sci Med 59, 553–565.
29. DJ Kaufman , JM Bollinger , RL Dvoskin (2012) Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing. J Genet Couns 21, 413–422.
30. CM McBride , CH Wade & KA Kaphingst (2010) Consumers' views of direct-to-consumer genetic information. Annu Rev Genomics Hum Genet 11, 427–446.
31. ML McGowan , JR Fishman & MA Lambrix (2010) Personal genomics and individual identities: motivations and moral imperatives of early users. New Genet Soc 29, 261–290.
32. Y Su , HC Howard & P Borry (2011) Users' motivations to purchase direct-to-consumer genome-wide testing: an exploratory study of personal stories. J Community Genet 2, 135–146.
33. KA Goddard , D Duquette , A Zlot (2009) Public awareness and use of direct-to-consumer genetic tests: results from 3 state population-based surveys, 2006. Am J Public Health 99, 442–445.
34. LF Cherkas , JM Harris , E Levinson (2010) A survey of UK public interest in internet-based personal genome testing. PLoS ONE 5, e13473.
35. KA Kaphingst , CM McBride , C Wade (2012) Patients' understanding of and responses to multiplex genetic susceptibility test results. Genet Med 14, 681–687.
36. S Hogarth (2010) Myths, misconceptions and myopia: searching for clarity in the debate about the regulation of consumer genetics. Public Health Genomics 13, 322–326.
40. F Becker , CG van El , D Ibarreta (2011) Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders. Eur J Hum Genet 19, Suppl. 1, S6–S44.
41. P Borry , RE van Hellemondt , D Sprumont (2012) Legislation on direct-to-consumer genetic testing in seven European countries. Eur J Hum Genet 20, 715–721.
45. CF Wright , A Hall & RL Zimmern (2011) Regulating direct-to-consumer genetic tests: what is all the fuss about? Genet Med 13, 295–300.
46. T Caulfield (2011) Direct-to-consumer testing: if consumers are not anxious, why are policymakers? Hum Genet 130, 23–25.
48. S Nettleton (2004) The emergence of e-scaped medicine. Sociology 38, 661–79.
51. B Prainsack , J Reardon , R Hindmarsh (2008) Personal genomes: misdirected precaution. Nature 456, 34–35.